0 results for 'Kraft Foods Group Inc'
Paul Weiss Scores Lead Role on IBM's $33B Red Hat Buy
A handful of large law firms—but not Cravath—are advising on the largest acquisition ever of a software company.Further Developments in Patent Venue and How They May Affect Calif. Corporations
Over a year ago, the Supreme Court held in TC Heartland v. Kraft Food Groups, that venue for patent suits against domestic corporations is limited to either the defendant's state of incorporation, or where the defendant has a regular place of business and committed allegedly infringing acts.Orrick Snags Weil Gotshal's Patent Litigation Co-Chair
Twenty-five year Weil Gotshal veteran (and former Orrick associate) Jared Bobrow joins Tuesday as co-lead of Orrick's global IP practice.Federal Circuit Rejects Bid to Limit Venue for Foreign Companies
The U.S. Court of Appeals for the Federal Circuit on Wednesday refused to place any restrictions on where foreign companies may be sued for patent infringement in the wake of the U.S. Supreme Court's TC Heartland ruling.Latham Poaches IP Litigator Tara Elliott From Wilmer
She brings experience and connections from the busy District of Delaware and the Federal Circuit.Daily Dicta: Bitter Brew: What Went Wrong in California's Coffee Lawsuit
Los Angeles County Superior Court Judge Elihu Berle penned an unpersuasive opinion that is woefully lacking in analysis or explanation. The consequences for the coffee industry will be huge.Disputes Over Venue in Patent Litigation
While those courts that have weighed in on work-at-home employees have come to similar conclusions, it remains to be seen what factors—if any—may complicate this analysis.Kirkland Recruits Cravath Deal Pro Eric Schiele
Cravath, Swaine & Moore M&A partner Eric Schiele has become the third notable partner to leave the firm in recent years for Kirkland & Ellis. The moves comes amid the retirement of Susan Webster, the former head of Cravath's general corporate practice.In Latest Lateral Payoff, Paul Weiss Grabs Role in Bioverativ Sale
Scott Barshay left Cravath, Swaine & Moore in 2016. At Paul Weiss, he has been compiling a growing list of clients with ties to his old firm. His most recent deal is the nearly $12 billion sale of drugmaker Bioverativ.Corporate Transparency Act Resource Kit
Brought to you by Wolters Kluwer
Download Now
Revenue, Profit, Cash: Managing Law Firms for Success
Brought to you by Juris Ledger
Download Now
Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now